Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-06-17

AUTHORS

Yugo Yamashita, Takeshi Morimoto, Frederikus A. Klok, Stefano Barco, Yuji Nishimoto, Takao Kato, Koh Ono, Takeshi Kimura

ABSTRACT

There is a paucity of data on anticoagulation strategies and clinical outcomes after bleeding events for venous thromboembolism (VTE). In a multicenter Japanese registry enrolling 3027 patients with acute symptomatic VTE, after excluding 430 patients with thrombolysis and 207 patients without anticoagulation therapy, the current study population consisted of 2390 patients, who were divided into patients with major bleeding, clinically relevant non-major (CRNM) bleeding and no bleeding during anticoagulation therapy. All-cause death at 90 days after the bleeding events was evaluated as the primary outcome. There were 189 patients with major bleeding, 147 patients with CRNM bleeding, and 2054 patients without bleeding. Among 189 patients with major bleeding, 142 patients (75%) discontinued anticoagulants, of whom patients with temporary discontinuation and those with permanent discontinuation accounted for 63 patients (44%) and 79 patients (56%), and 58 patients (30.7%) died within 90 days after the bleeding events. The multivariable logistic regression model among patients with bleeding events revealed that active cancer and bleeding events within 90 days after VTE diagnosis were independently associated with 90-day mortality after the bleeding events (active cancer: OR 5.05, 95%CI 2.82–9.05; bleeding events within 90 days after VTE diagnosis: OR 2.23, 95%CI 1.25–3.96). In this practice-based large registry, anticoagulants were frequently discontinued in patients who experienced major bleeding events during anticoagulation therapy and nearly half of them restarted anticoagulants with mortality rate of approximately 30% within 90 days after the bleeding events, and active cancer was the most prevalent cause of death.Clinical trial registration COMMAND VTE Registry: http://www.umin.ac.jp/ctr/index.htm. Unique identifier: UMIN000021132. More... »

PAGES

1-11

References to SciGraph publications

  • 2015-05-07. Venous thrombosis in NATURE REVIEWS DISEASE PRIMERS
  • 2018-05-17. Pulmonary embolism in NATURE REVIEWS DISEASE PRIMERS
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s11239-022-02665-x

    DOI

    http://dx.doi.org/10.1007/s11239-022-02665-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1148759863

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/35713842


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamashita", 
            "givenName": "Yugo", 
            "id": "sg:person.01012471043.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012471043.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan", 
              "id": "http://www.grid.ac/institutes/grid.272264.7", 
              "name": [
                "Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Morimoto", 
            "givenName": "Takeshi", 
            "id": "sg:person.011273662612.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany", 
              "id": "http://www.grid.ac/institutes/grid.410607.4", 
              "name": [
                "Department of Medicine, Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands", 
                "Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Klok", 
            "givenName": "Frederikus A.", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.412004.3", 
              "name": [
                "Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany", 
                "Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Barco", 
            "givenName": "Stefano", 
            "id": "sg:person.01002573041.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002573041.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan", 
              "id": "http://www.grid.ac/institutes/grid.413697.e", 
              "name": [
                "Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nishimoto", 
            "givenName": "Yuji", 
            "id": "sg:person.0652165442.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652165442.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kato", 
            "givenName": "Takao", 
            "id": "sg:person.01372163341.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372163341.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ono", 
            "givenName": "Koh", 
            "id": "sg:person.01070333054.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070333054.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan", 
              "id": "http://www.grid.ac/institutes/grid.258799.8", 
              "name": [
                "Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kimura", 
            "givenName": "Takeshi", 
            "id": "sg:person.012173163322.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrdp.2015.6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042197832", 
              "https://doi.org/10.1038/nrdp.2015.6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrdp.2018.28", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104018594", 
              "https://doi.org/10.1038/nrdp.2018.28"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2022-06-17", 
        "datePublishedReg": "2022-06-17", 
        "description": "There is a paucity of data on anticoagulation strategies and clinical outcomes after bleeding events for venous thromboembolism (VTE). In a multicenter Japanese registry enrolling 3027 patients with acute symptomatic VTE, after excluding 430 patients with thrombolysis and 207 patients without anticoagulation therapy, the current study population consisted of 2390 patients, who were divided into patients with major bleeding, clinically relevant non-major (CRNM) bleeding and no bleeding during anticoagulation therapy. All-cause death at 90\u00a0days after the bleeding events was evaluated as the primary outcome. There were 189 patients with major bleeding, 147 patients with CRNM bleeding, and 2054 patients without bleeding. Among 189 patients with major bleeding, 142 patients (75%) discontinued anticoagulants, of whom patients with temporary discontinuation and those with permanent discontinuation accounted for 63 patients (44%) and 79 patients (56%), and 58 patients (30.7%) died within 90\u00a0days after the bleeding events. The multivariable logistic regression model among patients with bleeding events revealed that active cancer and bleeding events within 90\u00a0days after VTE diagnosis were independently associated with 90-day mortality after the bleeding events (active cancer: OR 5.05, 95%CI 2.82\u20139.05; bleeding events within 90\u00a0days after VTE diagnosis: OR 2.23, 95%CI 1.25\u20133.96). In this practice-based large registry, anticoagulants were frequently discontinued in patients who experienced major bleeding events during anticoagulation therapy and nearly half of them restarted anticoagulants with mortality rate of approximately 30% within 90\u00a0days after the bleeding events, and active cancer was the most prevalent cause of death.Clinical trial registration COMMAND VTE Registry: http://www.umin.ac.jp/ctr/index.htm. Unique identifier: UMIN000021132.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s11239-022-02665-x", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1113719", 
            "issn": [
              "0929-5305", 
              "1573-742X"
            ], 
            "name": "Journal of Thrombosis and Thrombolysis", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }
        ], 
        "keywords": [
          "anticoagulation therapy", 
          "venous thromboembolism", 
          "major bleeding", 
          "active cancer", 
          "anticoagulation strategies", 
          "clinical outcomes", 
          "Japanese Registry", 
          "acute symptomatic venous thromboembolism", 
          "relevant non-major bleeding", 
          "multivariable logistic regression model", 
          "multicenter Japanese registry", 
          "symptomatic venous thromboembolism", 
          "non-major bleeding", 
          "major bleeding events", 
          "current study population", 
          "paucity of data", 
          "logistic regression models", 
          "CRNM bleeding", 
          "VTE diagnosis", 
          "bleeding events", 
          "permanent discontinuation", 
          "temporary discontinuation", 
          "primary outcome", 
          "large registries", 
          "study population", 
          "bleeding", 
          "patients", 
          "mortality rate", 
          "prevalent cause", 
          "therapy", 
          "anticoagulants", 
          "registry", 
          "thromboembolism", 
          "discontinuation", 
          "outcomes", 
          "cancer", 
          "days", 
          "regression models", 
          "death", 
          "thrombolysis", 
          "mortality", 
          "diagnosis", 
          "events", 
          "cause", 
          "paucity", 
          "population", 
          "half", 
          "strategies", 
          "rate", 
          "data", 
          "model"
        ], 
        "name": "Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry", 
        "pagination": "1-11", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1148759863"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s11239-022-02665-x"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "35713842"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s11239-022-02665-x", 
          "https://app.dimensions.ai/details/publication/pub.1148759863"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-09-02T16:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_935.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s11239-022-02665-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11239-022-02665-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11239-022-02665-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11239-022-02665-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11239-022-02665-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    176 TRIPLES      21 PREDICATES      76 URIs      66 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s11239-022-02665-x schema:about anzsrc-for:11
    2 anzsrc-for:1102
    3 schema:author Na8c2dd1acd6a468e9e2cfb37bf7cd437
    4 schema:citation sg:pub.10.1038/nrdp.2015.6
    5 sg:pub.10.1038/nrdp.2018.28
    6 schema:datePublished 2022-06-17
    7 schema:datePublishedReg 2022-06-17
    8 schema:description There is a paucity of data on anticoagulation strategies and clinical outcomes after bleeding events for venous thromboembolism (VTE). In a multicenter Japanese registry enrolling 3027 patients with acute symptomatic VTE, after excluding 430 patients with thrombolysis and 207 patients without anticoagulation therapy, the current study population consisted of 2390 patients, who were divided into patients with major bleeding, clinically relevant non-major (CRNM) bleeding and no bleeding during anticoagulation therapy. All-cause death at 90 days after the bleeding events was evaluated as the primary outcome. There were 189 patients with major bleeding, 147 patients with CRNM bleeding, and 2054 patients without bleeding. Among 189 patients with major bleeding, 142 patients (75%) discontinued anticoagulants, of whom patients with temporary discontinuation and those with permanent discontinuation accounted for 63 patients (44%) and 79 patients (56%), and 58 patients (30.7%) died within 90 days after the bleeding events. The multivariable logistic regression model among patients with bleeding events revealed that active cancer and bleeding events within 90 days after VTE diagnosis were independently associated with 90-day mortality after the bleeding events (active cancer: OR 5.05, 95%CI 2.82–9.05; bleeding events within 90 days after VTE diagnosis: OR 2.23, 95%CI 1.25–3.96). In this practice-based large registry, anticoagulants were frequently discontinued in patients who experienced major bleeding events during anticoagulation therapy and nearly half of them restarted anticoagulants with mortality rate of approximately 30% within 90 days after the bleeding events, and active cancer was the most prevalent cause of death.Clinical trial registration COMMAND VTE Registry: http://www.umin.ac.jp/ctr/index.htm. Unique identifier: UMIN000021132.
    9 schema:genre article
    10 schema:isAccessibleForFree false
    11 schema:isPartOf sg:journal.1113719
    12 schema:keywords CRNM bleeding
    13 Japanese Registry
    14 VTE diagnosis
    15 active cancer
    16 acute symptomatic venous thromboembolism
    17 anticoagulants
    18 anticoagulation strategies
    19 anticoagulation therapy
    20 bleeding
    21 bleeding events
    22 cancer
    23 cause
    24 clinical outcomes
    25 current study population
    26 data
    27 days
    28 death
    29 diagnosis
    30 discontinuation
    31 events
    32 half
    33 large registries
    34 logistic regression models
    35 major bleeding
    36 major bleeding events
    37 model
    38 mortality
    39 mortality rate
    40 multicenter Japanese registry
    41 multivariable logistic regression model
    42 non-major bleeding
    43 outcomes
    44 patients
    45 paucity
    46 paucity of data
    47 permanent discontinuation
    48 population
    49 prevalent cause
    50 primary outcome
    51 rate
    52 registry
    53 regression models
    54 relevant non-major bleeding
    55 strategies
    56 study population
    57 symptomatic venous thromboembolism
    58 temporary discontinuation
    59 therapy
    60 thromboembolism
    61 thrombolysis
    62 venous thromboembolism
    63 schema:name Anticoagulation strategies and clinical outcomes after bleeding events during anticoagulation therapy for venous thromboembolism in the practice-based Japanese registry
    64 schema:pagination 1-11
    65 schema:productId N920dc2583af2499898dd11ed4a4072f2
    66 Nabc02932e751485999c4c446633878e4
    67 Nafa896ae5f59425da51af9a20ce1daab
    68 schema:sameAs https://app.dimensions.ai/details/publication/pub.1148759863
    69 https://doi.org/10.1007/s11239-022-02665-x
    70 schema:sdDatePublished 2022-09-02T16:08
    71 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    72 schema:sdPublisher Na1683c8758a84bd9907504a48f863866
    73 schema:url https://doi.org/10.1007/s11239-022-02665-x
    74 sgo:license sg:explorer/license/
    75 sgo:sdDataset articles
    76 rdf:type schema:ScholarlyArticle
    77 N4c087c6dbfee433c89372f03e1b6a346 rdf:first sg:person.01002573041.08
    78 rdf:rest N9157337495874212b6314a0d73bf13b0
    79 N5c4a27351fd04d88a1c0c0878d712d53 rdf:first sg:person.01372163341.41
    80 rdf:rest N6d4dab92aab544bfa7a7f98e7faaf0d5
    81 N66f42c3b08ec45ca9dc17ce643441493 rdf:first sg:person.011273662612.03
    82 rdf:rest Nec9a54fe2cac40f4990360f5f0d8f940
    83 N6d4dab92aab544bfa7a7f98e7faaf0d5 rdf:first sg:person.01070333054.04
    84 rdf:rest Nd17867b8b29a4e5aa1f553e272e4205e
    85 N9157337495874212b6314a0d73bf13b0 rdf:first sg:person.0652165442.55
    86 rdf:rest N5c4a27351fd04d88a1c0c0878d712d53
    87 N920dc2583af2499898dd11ed4a4072f2 schema:name pubmed_id
    88 schema:value 35713842
    89 rdf:type schema:PropertyValue
    90 Na1683c8758a84bd9907504a48f863866 schema:name Springer Nature - SN SciGraph project
    91 rdf:type schema:Organization
    92 Na8c2dd1acd6a468e9e2cfb37bf7cd437 rdf:first sg:person.01012471043.12
    93 rdf:rest N66f42c3b08ec45ca9dc17ce643441493
    94 Nabc02932e751485999c4c446633878e4 schema:name dimensions_id
    95 schema:value pub.1148759863
    96 rdf:type schema:PropertyValue
    97 Nad07a5685a904ad984d29cf1f85bc325 schema:affiliation grid-institutes:grid.410607.4
    98 schema:familyName Klok
    99 schema:givenName Frederikus A.
    100 rdf:type schema:Person
    101 Nafa896ae5f59425da51af9a20ce1daab schema:name doi
    102 schema:value 10.1007/s11239-022-02665-x
    103 rdf:type schema:PropertyValue
    104 Nd17867b8b29a4e5aa1f553e272e4205e rdf:first sg:person.012173163322.36
    105 rdf:rest rdf:nil
    106 Nec9a54fe2cac40f4990360f5f0d8f940 rdf:first Nad07a5685a904ad984d29cf1f85bc325
    107 rdf:rest N4c087c6dbfee433c89372f03e1b6a346
    108 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    109 schema:name Medical and Health Sciences
    110 rdf:type schema:DefinedTerm
    111 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    112 schema:name Cardiorespiratory Medicine and Haematology
    113 rdf:type schema:DefinedTerm
    114 sg:journal.1113719 schema:issn 0929-5305
    115 1573-742X
    116 schema:name Journal of Thrombosis and Thrombolysis
    117 schema:publisher Springer Nature
    118 rdf:type schema:Periodical
    119 sg:person.01002573041.08 schema:affiliation grid-institutes:grid.412004.3
    120 schema:familyName Barco
    121 schema:givenName Stefano
    122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002573041.08
    123 rdf:type schema:Person
    124 sg:person.01012471043.12 schema:affiliation grid-institutes:grid.258799.8
    125 schema:familyName Yamashita
    126 schema:givenName Yugo
    127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012471043.12
    128 rdf:type schema:Person
    129 sg:person.01070333054.04 schema:affiliation grid-institutes:grid.258799.8
    130 schema:familyName Ono
    131 schema:givenName Koh
    132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070333054.04
    133 rdf:type schema:Person
    134 sg:person.011273662612.03 schema:affiliation grid-institutes:grid.272264.7
    135 schema:familyName Morimoto
    136 schema:givenName Takeshi
    137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011273662612.03
    138 rdf:type schema:Person
    139 sg:person.012173163322.36 schema:affiliation grid-institutes:grid.258799.8
    140 schema:familyName Kimura
    141 schema:givenName Takeshi
    142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012173163322.36
    143 rdf:type schema:Person
    144 sg:person.01372163341.41 schema:affiliation grid-institutes:grid.258799.8
    145 schema:familyName Kato
    146 schema:givenName Takao
    147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372163341.41
    148 rdf:type schema:Person
    149 sg:person.0652165442.55 schema:affiliation grid-institutes:grid.413697.e
    150 schema:familyName Nishimoto
    151 schema:givenName Yuji
    152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0652165442.55
    153 rdf:type schema:Person
    154 sg:pub.10.1038/nrdp.2015.6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042197832
    155 https://doi.org/10.1038/nrdp.2015.6
    156 rdf:type schema:CreativeWork
    157 sg:pub.10.1038/nrdp.2018.28 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104018594
    158 https://doi.org/10.1038/nrdp.2018.28
    159 rdf:type schema:CreativeWork
    160 grid-institutes:grid.258799.8 schema:alternateName Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan
    161 schema:name Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, 54 Shogoin Kawahara-cho, Sakyo-ku, 606-8507, Kyoto, Japan
    162 rdf:type schema:Organization
    163 grid-institutes:grid.272264.7 schema:alternateName Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan
    164 schema:name Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan
    165 rdf:type schema:Organization
    166 grid-institutes:grid.410607.4 schema:alternateName Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany
    167 schema:name Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany
    168 Department of Medicine, Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, The Netherlands
    169 rdf:type schema:Organization
    170 grid-institutes:grid.412004.3 schema:alternateName Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland
    171 schema:name Center for Thrombosis and Hemostasis, University Medical Center, Mainz, Germany
    172 Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland
    173 rdf:type schema:Organization
    174 grid-institutes:grid.413697.e schema:alternateName Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan
    175 schema:name Department of Cardiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan
    176 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...